Market-Moving News for June 12th
$BMR
$ORCL
$RNA
Computer Software: Prepackaged Software
Technology
Computer Software: Prepackaged Software
Technology
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/13/2025 | $70.00 | Buy | Citigroup | |
| 3/12/2025 | $72.00 | Outperform | BMO Capital Markets | |
| 3/11/2025 | $205.00 → $175.00 | Market Perform | BMO Capital Markets | |
| 3/7/2025 | $70.00 | Sector Outperform | Scotiabank | |
| 3/3/2025 | Sell → Neutral | Monness Crespi & Hardt | ||
| 1/17/2025 | $214.00 | Overweight | Cantor Fitzgerald | |
| 12/20/2024 | $130.00 | Neutral → Sell | Monness Crespi & Hardt | |
| 12/20/2024 | $72.00 | Buy | H.C. Wainwright |
144 - Avidity Biosciences, Inc. (0001599901) (Subject)
10-Q - ORACLE CORP (0001341439) (Filer)
8-K - ORACLE CORP (0001341439) (Filer)
4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
Citigroup initiated coverage of Avidity Biosciences with a rating of Buy and set a new price target of $70.00
BMO Capital Markets initiated coverage of Avidity Biosciences with a rating of Outperform and set a new price target of $72.00
BMO Capital Markets reiterated coverage of Oracle with a rating of Market Perform and set a new price target of $175.00 from $205.00 previously
SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)
SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)
SC 13G - Avidity Biosciences, Inc. (0001599901) (Subject)
Brings Oracle AI to the pit wall to increase efficiency of sporting regulation reviews Standardizes on Oracle Virtualization from the factory to the track to increase flexibility, streamline IT infrastructure, and simplify training AUSTIN, Texas and MILTON KEYNES, England, March 13, 2025 /PRNewswire/ -- Oracle Red Bull Racing, the multiple championship winning Formula One team, is expanding its use of Oracle Cloud and AI technologies on and off the track as the team kicks off the 2025 Formula One (F1) season. "Since the start of our partnership, Oracle has given us a technica
New agentic AI capabilities in Oracle Investigation Hub can reduce manual work to help uncover and thwart financial schemes faster AUSTIN, Texas, March 12, 2025 /PRNewswire/ -- Oracle Financial Services is supercharging its Investigation Hub Cloud Service with the addition of a broad class of AI agents and agentic workflows that enable financial firms to automate investigative processes needed to uncover complex patterns and fight financial crime. The agents help improve the overall quality and speed of reviewing suspicious activity by using generative AI-driven narratives to supplement investigators' own analysis. This can save valuable time and resources by offloading many traditionally ma
Aravindhan Veerapandiyan, MD, Associate Professor of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital and EXPLORE44® trial investigator, will present topline del-zota data from Phase 1/2 EXPLORE44 trial at 2025 MDA Clinical & Scientific Conference in Dallas, Texas Avidity to host investor and analyst webcast event March 17, 2025, at 8:00 a.m. ET Key opinion leaders to participate in Avidity sponsored industry forum event "Advancing RNA Therapeutics", March 17, 2025, at 7:00 a.m. CT/8:00 a.m. ET SAN DIEGO, March 12, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (NASDAQ:RNA), a biopharmaceutical company committed to delivering a new class of RNA therap
Q3 Remaining Performance Obligations $130 billion, up 62% in USD & up 63% in constant currencyQ3 GAAP Earnings per Share up 20% to $1.02, Non-GAAP Earnings per Share up 4% to $1.47Q3 Total Revenue $14.1 billion, up 6% in USD and up 8% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $6.2 billion, up 23% in USD and up 25% in constant currencyQ3 Cloud Infrastructure (IaaS) Revenue $2.7 billion, up 49% in USD and up 51% in constant currencyQ3 Cloud Application (SaaS) Revenue $3.6 billion, up 9% in USD and up 10% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $0.9 billion, up 16% in USD and up 18% in constant currencyQ3 NetSuite Cloud ERP (SaaS) Revenue $0.9 billion, up 16% in USD a
Earnings Results to be released on March 10, 2025, After the Close of the Market AUSTIN, Texas, March 3, 2025 /PRNewswire/ -- Oracle Corporation today announced that its third quarter fiscal year 2025 results will be released on Monday, March 10th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results. The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, autonomous i
Q2 GAAP Earnings per Share up 24% to $1.10, Non-GAAP Earnings per Share up 10% to $1.47Q2 Total Revenue $14.1 billion, up 9% in both USD and constant currencyQ2 Total Remaining Performance Obligations $97 billion, up 49% in USD & 50% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $5.9 billion, up 24% in both USD and constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $2.4 billion, up 52% in both USD and constant currencyQ2 Cloud Application (SaaS) Revenue $3.5 billion, up 10% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $0.9 billion, up 18% in both USD and constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $0.9 billion, up 20% in USD and 19% in constant c
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi
Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th
Built for maximum security and AI innovation, Oracle transforms the EHR from an administrative burden into a clinical asset to help improve care delivery NASHVILLE, Tenn., Oct. 29, 2024 /PRNewswire/ -- Oracle Health Summit -- Today, Oracle is previewing its next-generation electronic health record (EHR) to thousands of customers and partners attending the Oracle Health Summit. Built from the ground up to take advantage of the high performance and military-grade security1 of Oracle Cloud Infrastructure (OCI), the EHR is designed to embed AI across the entire clinical workflow to automate processes, deliver insights at the point of care, and dramatically simplify appointment prep, documentatio